These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2945783)

  • 1. Prolonged administration of human atrial natriuretic peptide in healthy men. Reduced aldosteronotropic effect of angiotensin II.
    Vierhapper H; Nowotny P; Waldhäusl W
    Hypertension; 1986 Nov; 8(11):1040-3. PubMed ID: 2945783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of human atrial natriuretic peptide on angiotensin II-induced secretion of aldosterone in man.
    Vierhapper H
    Klin Wochenschr; 1986; 64 Suppl 6():50-2. PubMed ID: 2948063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effects of atrial natriuretic peptide and brain natriuretic peptide on the aldosterone and pressor responses to angiotensin II in man.
    Cargill RI; Struthers AD; Lipworth BJ
    Clin Sci (Lond); 1995 Jan; 88(1):81-6. PubMed ID: 7705006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrial natriuretic peptide inhibits the aldosterone response to angiotensin II in man.
    Anderson JV; Struthers AD; Payne NN; Slater JD; Bloom SR
    Clin Sci (Lond); 1986 May; 70(5):507-12. PubMed ID: 2938872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of atrial natriuretic factor in changes in the responsiveness of aldosterone to angiotensin II secondary to sodium loading and depletion in man.
    Tuchelt H; Eschenhagen G; Bähr V; Schwietzer G; Thiede HM; Oelkers W
    Clin Sci (Lond); 1990 Jul; 79(1):57-65. PubMed ID: 2167792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Four-hour infusions of synthetic atrial natriuretic peptide in normal volunteers.
    Biollaz J; Nussberger J; Porchet M; Brunner-Ferber F; Otterbein ES; Gomez H; Waeber B; Brunner HR
    Hypertension; 1986 Jun; 8(6 Pt 2):II96-105. PubMed ID: 2941372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioactivity and metabolism of C-type natriuretic peptide in normal man.
    Hunt PJ; Richards AM; Espiner EA; Nicholls MG; Yandle TG
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1428-35. PubMed ID: 8200946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of atrial natriuretic peptide on blood pressure, guanosine 3':5'-cyclic monophosphate release and blood volume in uraemic patients.
    Jespersen B; Eiskjaer H; Pedersen EB
    Clin Sci (Lond); 1990 Jan; 78(1):67-73. PubMed ID: 2153498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term hypotensive and renal effects of atrial natriuretic peptide.
    Granger JP; Opgenorth TJ; Salazar J; Romero JC; Burnett JC
    Hypertension; 1986 Jun; 8(6 Pt 2):II112-6. PubMed ID: 2941368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of plasma sodium on aldosterone secretion during angiotensin II stimulation in normal humans.
    Merrill DC; Ebert TJ; Skelton MM; Cowley AW
    Hypertension; 1989 Aug; 14(2):164-9. PubMed ID: 2527200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired aldosterone production by long-term infusion of atrial natriuretic factor.
    Nagano M; Bravo EL
    Am J Physiol; 1990 Jan; 258(1 Pt 1):E51-6. PubMed ID: 2137294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of incremental infusions of atrial natriuretic factor on aldosterone, renin, and blood pressure in humans.
    Oelkers W; Kleiner S; Bähr V
    Hypertension; 1988 Oct; 12(4):462-7. PubMed ID: 2971619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged administration of human atrial natriuretic peptide in healthy men: evanescent effects on diuresis and natriuresis.
    Waldhäusl W; Vierhapper H; Nowotny P
    J Clin Endocrinol Metab; 1986 May; 62(5):956-9. PubMed ID: 2937802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human C-type natriuretic peptide: effects on the haemodynamic and endocrine responses to angiotensin II.
    Cargill RI; Struthers AD; Lipworth BJ
    Cardiovasc Res; 1995 Jan; 29(1):108-11. PubMed ID: 7895227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interaction between atrial natriuretic peptides and angiotensin II in controlling sodium and water excretion in the rat.
    Chamienia AL; Johns EJ
    Br J Pharmacol; 1991 Aug; 103(4):1893-8. PubMed ID: 1833019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atrial natriuretic peptide infusion in primary aldosteronism. Renal, hemodynamic and hormonal effects.
    Rocco S; Opocher G; Carpenè G; Mantero F
    Am J Hypertens; 1990 Sep; 3(9):668-73. PubMed ID: 2145872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of physiological levels of atrial natriuretic peptide on hormone secretion: inhibition of angiotensin-induced aldosterone secretion and renin release in normal man.
    Cuneo RC; Espiner EA; Nicholls MG; Yandle TG; Livesey JH
    J Clin Endocrinol Metab; 1987 Oct; 65(4):765-72. PubMed ID: 2821056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrial natriuretic hormone and aldosterone regulation in salt-depleted state.
    Shenker Y
    Am J Physiol; 1989 Oct; 257(4 Pt 1):E583-7. PubMed ID: 2529776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of synthetic atrial natriuretic factor (ANF) on renin-aldosterone axis in the conscious newborn calf.
    Amadieu M; Giry J; Barlet JP
    J Dev Physiol; 1989 Jan; 11(1):15-8. PubMed ID: 2529306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ageing and blood pressure regulation: dose-response relationships for angiotensin, blood pressure, atrial natriuretic peptide and aldosterone in normal subjects of varying ages.
    Finn WL; Tunny TJ; Klemm SA; Ryan SJ; Gordon RD
    Clin Exp Pharmacol Physiol; 1993 May; 20(5):392-4. PubMed ID: 8324930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.